Recombinant humanized monoclonal antibody to IL-13.
Applicazioni
ELISA, FACS, Functional Assay, In Vivo
Reattività
Human
Specie ospite
Humanized
Clonalità
Monoclonal
Isotipo
IgG1
Catene leggere
kappa
Coniugare
Unconjugated
Purificazione
Protein A affinity chromatography.
Concentrazione
Reconstitution dependent.
Peso molecolare
This antibody has a predicted MW of 145 kDa.
Purezza
> 90% (by SDS-PAGE and SEC-HPLC).
Forma del prodotto
Lyophilized
Ricostituzione
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulazione
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Conservazione
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Anrukinzumab Biosimilar - Anti-IL-13 Antibody - Low endotoxin, Azide free (A323284) under reducing (R) conditions confirms that the purity of this antibody is greater than 90%.
SEC-HPLC analysis of Anrukinzumab Biosimilar - Anti-IL-13 Antibody - Low endotoxin, Azide free (A323284) confirms that the purity of this antibody is greater than 95%.
Prodotti alternativi a Anti-IL-13 Anticorpo (A323284)